IPCA Laboratories Limited — Dividend/Bonus, 29-05-2025: Dividend

Ipca Laboratories has announced a board meeting approving the financial results for the quarter and half-year. The Board has proposed a final dividend of Rs. 2/- per share (200%), subject to shareholder approval, with a record date set for entitlement.

Key performance highlights show strong growth: standalone net income rose 9% to Rs. 1659.93 Cr, net profit before exceptional items jumped 36% to Rs. 216.49 Cr; consolidated net income increased 11% to Rs. 2272.51 Cr, with net profit nearly doubling to Rs. 270.83 Cr. FY25 saw 8-15% revenue growth and 40-56% profit gains. The dividend reflects solid earnings momentum and healthy cash flows for shareholders.